Absence de Lyse adipocytaire avec EndyMed 3DEEP
publié le 30-04-2011 à 07:46 dans la rubrique 010. Actualités du Centre Laser Sorbonne
"Regarding the concern of some French physicians regarding lipolysis in RF treatments :
3 DEEP multisource RF technology uses multiple sources of RF to selectively drive heat into the skin.
While the optimal heat for collagen remodeling is around 50-55 degrees Celsius, epidermis should be kept at a temperature < 43 degrees Celsius.
Fat cells are reported to be destructed after 1-3 minutes at high temperature > 63 degrees Celsius. or after more than 15 minutes at temperatures > 43 deg.
Skin dimpling due to local lipolysis was reported after treatment with monopolar RF (Thermage) in which the treatment produces high temperature on a small static contact point (stamping method) .
In contrast to monopolar /Unipolar technology (Thermage, Accent, Exiliis ) that drive RF energy from a small electrode on the skin surface vertically through the skin to a back/ground electrode, the 3DEEP delivers the energy through tissues with lower impedance = fibrous tissues = collagen. The circulatory motion of the EndyMed hand piece with its motion sensor further reduces the risk for heat concentration on a single point.
In depth thermal lab studies (figure 1) have shown clearly that energy is concentrated in collagenous tissue (upper picture stained blue) while fatty subcutaneous tissue is not heated. (<40 deg Celsius) .
These lab results, showing selective heating of fibrous tissue in the hypodermis, were clinically confirmed in multiple clinical studies and thousands of routine treatments using the EndyMed system . Lipolysis and skin dimpling were never reported during 3 DEEP treatments.
In conclusion :
The 3DEEP , unique thermal pattern assures skin tightening , body shaping, body contouring and anti cellulite effects through collagen remodeling without the risk of lipolysis possible with monopolar RF technologies.
Dr Yoram Harth Yoram Harth MD
Board Certified Dermatologist Founder, Chief Medical officer EndyMed Ltd."





